Schedule 13D ownership disclosure
TSCAN THERAPEUTICS INC
Security class unavailable · CUSIP: 89854M101
Event date: 2021-07-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,425,000
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-094915
- Form type
- SC 13D
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Jul 22, 2021
- Reporting period
- Jul 20, 2021
- Description
- Schedule 13D beneficial ownership